Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

NCT05597241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: apimostinel
DRUG: Placebo

Sponsor

Syndeio Biosciences, Inc